Itraconazole Nanosuspensions via Dual Centrifugation Media Milling: Impact of Formulation and Process Parameters on Particle Size and Solid-State Conversion as Well as Storage Stability

Nanocrystal suspensions proved to be a potent enabling principle for biopharmaceutics classification system class II drugs with dissolution limited bioavailability. In the example of itraconazole (ITZ) as a model drug combined with electrosteric stabilization using hydroxypropyl cellulose (HPC-SL),...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 14; no. 8; p. 1528
Main Authors Willmann, Ann-Cathrin, Berkenfeld, Kai, Faber, Thilo, Wachtel, Herbert, Boeck, Georg, Wagner, Karl G
Format Journal Article
LanguageEnglish
Published Basel MDPI AG 22.07.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Nanocrystal suspensions proved to be a potent enabling principle for biopharmaceutics classification system class II drugs with dissolution limited bioavailability. In the example of itraconazole (ITZ) as a model drug combined with electrosteric stabilization using hydroxypropyl cellulose (HPC-SL), sodium dodecyl sulfate (SDS) and polysorbate 80 (PS80), the impacts of formulation and process parameters of a dual centrifugal mill on material attributes such as particle size, zeta potential, particle morphology, storage stability and especially solid-state characteristics were evaluated. A minimal concentration of 0.9% (w/w) HPC-SL, 0.14% (w/w) SDS and 0.07% (w/w) PS80 was necessary for sufficient nanoparticle stabilization. Despite the minor effect of PS80, its presence was beneficial for electrosteric stabilization. Choosing lower stabilizer concentrations resulted in a pronounced increase in particle size due to agglomeration, which was confirmed by SEM imaging and a decrease in zeta potential in combination with an amorphization of the particles. Milling temperature had no significant impact on the particle size, whereas milling speed and the size of the milling beads used were found to have a strong impact on the critical material attributes such as particle size and polydispersity index. The smallest particle sizes could be obtained by using the smallest milling bead size. However, the smallest obtainable particle size could only be achieved by using two-fold stabilizer concentrations, as smaller particles exhibit a larger specific surface area.
AbstractList Nanocrystal suspensions proved to be a potent enabling principle for biopharmaceutics classification system class II drugs with dissolution limited bioavailability. In the example of itraconazole (ITZ) as a model drug combined with electrosteric stabilization using hydroxypropyl cellulose (HPC-SL), sodium dodecyl sulfate (SDS) and polysorbate 80 (PS80), the impacts of formulation and process parameters of a dual centrifugal mill on material attributes such as particle size, zeta potential, particle morphology, storage stability and especially solid-state characteristics were evaluated. A minimal concentration of 0.9% (w/w) HPC-SL, 0.14% (w/w) SDS and 0.07% (w/w) PS80 was necessary for sufficient nanoparticle stabilization. Despite the minor effect of PS80, its presence was beneficial for electrosteric stabilization. Choosing lower stabilizer concentrations resulted in a pronounced increase in particle size due to agglomeration, which was confirmed by SEM imaging and a decrease in zeta potential in combination with an amorphization of the particles. Milling temperature had no significant impact on the particle size, whereas milling speed and the size of the milling beads used were found to have a strong impact on the critical material attributes such as particle size and polydispersity index. The smallest particle sizes could be obtained by using the smallest milling bead size. However, the smallest obtainable particle size could only be achieved by using two-fold stabilizer concentrations, as smaller particles exhibit a larger specific surface area.
Nanocrystal suspensions proved to be a potent enabling principle for biopharmaceutics classification system class II drugs with dissolution limited bioavailability. In the example of itraconazole (ITZ) as a model drug combined with electrosteric stabilization using hydroxypropyl cellulose (HPC-SL), sodium dodecyl sulfate (SDS) and polysorbate 80 (PS80), the impacts of formulation and process parameters of a dual centrifugal mill on material attributes such as particle size, zeta potential, particle morphology, storage stability and especially solid-state characteristics were evaluated. A minimal concentration of 0.9% ( w / w ) HPC-SL, 0.14% ( w / w ) SDS and 0.07% ( w / w ) PS80 was necessary for sufficient nanoparticle stabilization. Despite the minor effect of PS80, its presence was beneficial for electrosteric stabilization. Choosing lower stabilizer concentrations resulted in a pronounced increase in particle size due to agglomeration, which was confirmed by SEM imaging and a decrease in zeta potential in combination with an amorphization of the particles. Milling temperature had no significant impact on the particle size, whereas milling speed and the size of the milling beads used were found to have a strong impact on the critical material attributes such as particle size and polydispersity index. The smallest particle sizes could be obtained by using the smallest milling bead size. However, the smallest obtainable particle size could only be achieved by using two-fold stabilizer concentrations, as smaller particles exhibit a larger specific surface area.
Audience Academic
Author Wagner, Karl G
Willmann, Ann-Cathrin
Berkenfeld, Kai
Faber, Thilo
Wachtel, Herbert
Boeck, Georg
AuthorAffiliation 1 Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany; ann-cathrin.willmann@boehringer-ingelheim.com
2 Department of Pharmaceutical Technology, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany; kaib@uni-bonn.de (K.B.); thilo.faber@uni-bonn.de (T.F.)
3 Device Development, Boehringer Ingelheim GmbH & Co. KG, Binger Straße 173, 55216 Ingelheim am Rhein, Germany; herbert.wachtel@boehringer-ingelheim.com
4 Department Discovery Research, Boehringer Ingelheim RCV GmbH & Co. KG, Dr.-Boehringer-Gasse 5-11, 1121 Vienna, Austria; georg.boeck@boehringer-ingelheim.com
AuthorAffiliation_xml – name: 4 Department Discovery Research, Boehringer Ingelheim RCV GmbH & Co. KG, Dr.-Boehringer-Gasse 5-11, 1121 Vienna, Austria; georg.boeck@boehringer-ingelheim.com
– name: 2 Department of Pharmaceutical Technology, University of Bonn, Gerhard-Domagk-Straße 3, 53121 Bonn, Germany; kaib@uni-bonn.de (K.B.); thilo.faber@uni-bonn.de (T.F.)
– name: 1 Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Straße 65, 88397 Biberach, Germany; ann-cathrin.willmann@boehringer-ingelheim.com
– name: 3 Device Development, Boehringer Ingelheim GmbH & Co. KG, Binger Straße 173, 55216 Ingelheim am Rhein, Germany; herbert.wachtel@boehringer-ingelheim.com
Author_xml – sequence: 1
  fullname: Willmann, Ann-Cathrin
– sequence: 2
  fullname: Berkenfeld, Kai
– sequence: 3
  fullname: Faber, Thilo
– sequence: 4
  fullname: Wachtel, Herbert
– sequence: 5
  fullname: Boeck, Georg
– sequence: 6
  fullname: Wagner, Karl G
BookMark eNptkl1vFCEUhiemxtban2BC4o03WxmYD_DCpFmtbtJqk9V4SQ4MTNnMwBaYJu0_89_JfkRdU7jg4zznhXPyviyOnHe6KF6X-JxSjt-tbyGMoPSUrIplhVlZE_asOCk557OKE3r0z_64OItxhfOgtGSUvyiOac04bRk9KX4tUgDlHTz6QaOv4Hyc4lq7aL2L6N4C-jjBgObapWDN1EPKAXStuxy5tsNgXf8eLcY1qIS8QZc-jNOwg8B16CZ4pWNENxBg1EmHiHIkn_LH83tL-6i33NIPtpstEySN5t7dZ3ArEdFPPQybdZl8gD6nJJB2sOnhVfHcwBD12X49LX5cfvo-_zK7-vZ5Mb-4mqmq5WlmamqINA3hXCqMG4mNMQygM8pIKkvVUgnMlEZKzYzENVSaNxirrpO845qeFoudbudhJdbBjhAehAcrthc-9GJfjiCMS4LbmrGaVqZseH5EsZI2bVXrui2z1oed1nqSo-7UpqswHIgeRpy9Fb2_F5xSQmqSBd7uBYK_m3RMYrRR5RaB036KgjQ8O6FuW5rRN_-hKz8Fl1slSIsb0pKqIX-pHnIB1hm_8cNGVFxkom1YQ-pMnT9B5dnp0Wb3aGPz_UFCvUtQwccYtPlTY4nFxsLiSQvT335P7JI
CitedBy_id crossref_primary_10_1016_j_ijpharm_2023_123455
crossref_primary_10_3390_ph16111519
crossref_primary_10_3390_pharmaceutics15020706
crossref_primary_10_1016_j_ejps_2023_106417
crossref_primary_10_1016_j_jddst_2024_105605
crossref_primary_10_1016_j_ijpharm_2023_123733
crossref_primary_10_3390_pharmaceutics15051520
Cites_doi 10.1007/s11095-016-1958-5
10.1016/j.ijpharm.2009.06.029
10.1039/C6RA16209F
10.1038/nrd1494
10.1016/j.ejpb.2010.01.011
10.1016/j.ijpharm.2017.07.047
10.1016/j.ijpharm.2012.11.044
10.1016/j.ijpharm.2016.09.046
10.1016/j.addr.2018.06.009
10.1016/j.ijpharm.2014.03.021
10.1016/j.ijpharm.2007.10.001
10.1016/j.apt.2018.09.039
10.1016/S0032-5910(99)00162-X
10.1016/j.ejps.2004.10.005
10.3109/03639045.2010.551775
10.1016/j.ijpharm.2019.04.082
10.1016/j.powtec.2009.05.007
10.1002/jps.21733
10.1016/S0040-6031(01)00563-9
10.1021/j150453a001
10.1021/ja02086a003
10.1016/0032-5910(95)02990-J
10.1515/zpch-1897-2233
10.1016/j.ijpharm.2017.04.001
10.1016/j.powtec.2018.08.014
10.1016/j.ejpb.2015.02.031
10.3390/pharmaceutics8020017
10.1016/j.ijpharm.2010.12.027
10.1111/j.2042-7158.2010.01022.x
10.1124/pr.112.005660
10.1002/jps.24155
10.14356/kona.1997013
10.1080/10717544.2020.1856224
10.1016/S0378-5173(02)00591-4
ContentType Journal Article
Copyright COPYRIGHT 2022 MDPI AG
2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: COPYRIGHT 2022 MDPI AG
– notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/pharmaceutics14081528
DatabaseName CrossRef
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Databases
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
Research Library Prep
Research Library
Research Library (Corporate)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef

Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1999-4923
ExternalDocumentID oai_doaj_org_article_289b207588534f169dfcc8136745e571
A724768625
10_3390_pharmaceutics14081528
GeographicLocations Germany
United States--US
GeographicLocations_xml – name: Germany
– name: United States--US
GrantInformation_xml – fundername: Boehringer Ingelheim Pharma GmbH & Co. KG.
– fundername: University of Bonn
GroupedDBID ---
3V.
53G
5VS
8G5
AADQD
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
AEAQA
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
F5P
FD6
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
OK1
P6G
PGMZT
PIMPY
PQQKQ
PROAC
RNS
RPM
TR2
TUS
RIG
7XB
8FK
MBDVC
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
ACUHS
ID FETCH-LOGICAL-c479t-f53f2bf6299bc006b0fff8aadfcfb3b1c73ba8f1fbbe8fb05a4e9600cddb9d9e3
IEDL.DBID RPM
ISSN 1999-4923
IngestDate Tue Dec 17 15:30:27 EST 2024
Tue Sep 17 20:50:44 EDT 2024
Wed Dec 04 14:52:58 EST 2024
Thu Dec 05 06:52:02 EST 2024
Tue Nov 19 21:40:59 EST 2024
Tue Nov 12 23:53:38 EST 2024
Fri Dec 06 08:55:29 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c479t-f53f2bf6299bc006b0fff8aadfcfb3b1c73ba8f1fbbe8fb05a4e9600cddb9d9e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2864-7191
0000-0001-9377-8038
0000-0001-5859-1315
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332252/
PMID 35893783
PQID 2706272462
PQPubID 2032349
ParticipantIDs doaj_primary_oai_doaj_org_article_289b207588534f169dfcc8136745e571
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9332252
proquest_miscellaneous_2695285773
proquest_journals_2706272462
gale_infotracmisc_A724768625
gale_infotracacademiconefile_A724768625
crossref_primary_10_3390_pharmaceutics14081528
PublicationCentury 2000
PublicationDate 20220722
PublicationDateYYYYMMDD 2022-07-22
PublicationDate_xml – month: 7
  year: 2022
  text: 20220722
  day: 22
PublicationDecade 2020
PublicationPlace Basel
PublicationPlace_xml – name: Basel
PublicationTitle Pharmaceutics
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – sequence: 0
  name: MDPI AG
– name: MDPI AG
– name: MDPI
References Li (ref_17) 2018; 339
Bhakay (ref_13) 2011; 37
Colombo (ref_30) 2009; 98
Rabinow (ref_5) 2004; 3
Kumar (ref_28) 2014; 466
Six (ref_12) 2005; 24
Derjaguin (ref_9) 1941; 14
Peltonen (ref_29) 2010; 62
Gao (ref_37) 1995; 84
Bobo (ref_3) 2016; 33
Yang (ref_33) 2010; 75
Sharma (ref_34) 2009; 380
Deng (ref_31) 2008; 351
Kwade (ref_38) 1997; 15
Peltonen (ref_22) 2018; 131
Li (ref_7) 2020; 28
Verma (ref_8) 2011; 406
Ostwald (ref_6) 1897; 22
Kumar (ref_15) 2015; 104
Williams (ref_1) 2013; 65
Six (ref_32) 2001; 376
Noyes (ref_2) 1897; 19
Verwey (ref_10) 1947; 51
Bilgili (ref_18) 2018; 29
Knieke (ref_19) 2009; 195
ref_24
Hagedorn (ref_40) 2019; 565
ref_23
Hagedorn (ref_11) 2017; 530
ref_20
Verreck (ref_35) 2003; 251
Li (ref_39) 2017; 524
ref_27
Tanaka (ref_21) 2016; 6
Bitterlich (ref_26) 2015; 92
Azad (ref_16) 2016; 513
Kwade (ref_36) 1999; 105
ref_4
Cerdeira (ref_14) 2013; 443
Gibbs (ref_25) 1873; s4-XII
References_xml – volume: 33
  start-page: 2373
  year: 2016
  ident: ref_3
  article-title: Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
  publication-title: Pharmaceut. Res.
  doi: 10.1007/s11095-016-1958-5
  contributor:
    fullname: Bobo
– ident: ref_24
– volume: 380
  start-page: 40
  year: 2009
  ident: ref_34
  article-title: Effect of Wet Milling Process on the Solid State of Indomethacin and Simvastatin
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2009.06.029
  contributor:
    fullname: Sharma
– volume: 6
  start-page: 87049
  year: 2016
  ident: ref_21
  article-title: Verification of the Mixing Processes of the Active Pharmaceutical Ingredient, Excipient and Lubricant in a Pharmaceutical Formulation Using a Resonant Acoustic Mixing Technology
  publication-title: RSC Adv.
  doi: 10.1039/C6RA16209F
  contributor:
    fullname: Tanaka
– volume: 3
  start-page: 785
  year: 2004
  ident: ref_5
  article-title: Nanosuspensions in Drug Delivery
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd1494
  contributor:
    fullname: Rabinow
– volume: 75
  start-page: 33
  year: 2010
  ident: ref_33
  article-title: Comparison of Bioavailability of Amorphous versus Crystalline Itraconazole Nanoparticles via Pulmonary Administration in Rats
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2010.01.011
  contributor:
    fullname: Yang
– volume: 530
  start-page: 79
  year: 2017
  ident: ref_11
  article-title: Dual Centrifugation—A New Technique for Nanomilling of Poorly Soluble Drugs and Formulation Screening by an DoE-Approach
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2017.07.047
  contributor:
    fullname: Hagedorn
– volume: 443
  start-page: 209
  year: 2013
  ident: ref_14
  article-title: Formulation and Drying of Miconazole and Itraconazole Nanosuspensions
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2012.11.044
  contributor:
    fullname: Cerdeira
– volume: 513
  start-page: 319
  year: 2016
  ident: ref_16
  article-title: Fast Dissolution of Poorly Water Soluble Drugs from Fluidized Bed Coated Nanocomposites: Impact of Carrier Size
  publication-title: Int. J. Pharmaceut.
  doi: 10.1016/j.ijpharm.2016.09.046
  contributor:
    fullname: Azad
– volume: 131
  start-page: 101
  year: 2018
  ident: ref_22
  article-title: Practical Guidelines for the Characterization and Quality Control of Pure Drug Nanoparticles and Nano-Cocrystals in the Pharmaceutical Industry
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2018.06.009
  contributor:
    fullname: Peltonen
– volume: 466
  start-page: 223
  year: 2014
  ident: ref_28
  article-title: Wet Milling Induced Physical and Chemical Instabilities of Naproxen Nano-Crystalline Suspensions
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2014.03.021
  contributor:
    fullname: Kumar
– ident: ref_23
– volume: 351
  start-page: 236
  year: 2008
  ident: ref_31
  article-title: Understanding a Relaxation Behavior in a Nanoparticle Suspension for Drug Delivery Applications
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2007.10.001
  contributor:
    fullname: Deng
– volume: 29
  start-page: 2941
  year: 2018
  ident: ref_18
  article-title: Impact of Polymers on the Aggregation of Wet-Milled Itraconazole Particles and Their Dissolution from Spray-Dried Nanocomposites
  publication-title: Adv. Powder Technol.
  doi: 10.1016/j.apt.2018.09.039
  contributor:
    fullname: Bilgili
– volume: 105
  start-page: 382
  year: 1999
  ident: ref_36
  article-title: Determination of the Most Important Grinding Mechanism in Stirred Media Mills by Calculating Stress Intensity and Stress Number
  publication-title: Powder Technol.
  doi: 10.1016/S0032-5910(99)00162-X
  contributor:
    fullname: Kwade
– volume: 24
  start-page: 179
  year: 2005
  ident: ref_12
  article-title: Clinical Study of Solid Dispersions of Itraconazole Prepared by Hot-Stage Extrusion
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2004.10.005
  contributor:
    fullname: Six
– volume: 37
  start-page: 963
  year: 2011
  ident: ref_13
  article-title: Novel Aspects of Wet Milling for the Production of Microsuspensions and Nanosuspensions of Poorly Water-Soluble Drugs
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.3109/03639045.2010.551775
  contributor:
    fullname: Bhakay
– volume: 565
  start-page: 187
  year: 2019
  ident: ref_40
  article-title: Rapid Development of API Nano-Formulations from Screening to Production Combining Dual Centrifugation and Wet Agitator Bead Milling
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2019.04.082
  contributor:
    fullname: Hagedorn
– volume: 195
  start-page: 25
  year: 2009
  ident: ref_19
  article-title: Identifying the Apparent and True Grinding Limit
  publication-title: Powder Technol.
  doi: 10.1016/j.powtec.2009.05.007
  contributor:
    fullname: Knieke
– volume: 98
  start-page: 3961
  year: 2009
  ident: ref_30
  article-title: Drug Mechanochemical Activation
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.21733
  contributor:
    fullname: Colombo
– volume: 376
  start-page: 175
  year: 2001
  ident: ref_32
  article-title: den Investigation of Thermal Properties of Glassy Itraconazole: Identification of a Monotropic Mesophase
  publication-title: Thermochim. Acta
  doi: 10.1016/S0040-6031(01)00563-9
  contributor:
    fullname: Six
– volume: 51
  start-page: 631
  year: 1947
  ident: ref_10
  article-title: Theory of the Stability of Lyophobic Colloids
  publication-title: J. Phys. Colloid Chem.
  doi: 10.1021/j150453a001
  contributor:
    fullname: Verwey
– ident: ref_27
– volume: 19
  start-page: 930
  year: 1897
  ident: ref_2
  article-title: The Rate of Solution of Solid Substances in Their Own Solutions
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja02086a003
  contributor:
    fullname: Noyes
– volume: 84
  start-page: 101
  year: 1995
  ident: ref_37
  article-title: Prediction of Product Size Distributions for a Stirred Ball Mill
  publication-title: Powder Technol.
  doi: 10.1016/0032-5910(95)02990-J
  contributor:
    fullname: Gao
– volume: 22
  start-page: 289
  year: 1897
  ident: ref_6
  article-title: Studien Über Die Bildung Und Umwandlung Fester Körper
  publication-title: Z. Phys. Chem.
  doi: 10.1515/zpch-1897-2233
  contributor:
    fullname: Ostwald
– volume: 524
  start-page: 178
  year: 2017
  ident: ref_39
  article-title: A Microhydrodynamic Rationale for Selection of Bead Size in Preparation of Drug Nanosuspensions via Wet Stirred Media Milling
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2017.04.001
  contributor:
    fullname: Li
– volume: 14
  start-page: 633
  year: 1941
  ident: ref_9
  article-title: Theory of the Stability of Strongly Charged Lyophobic Sols and of the Adhesion of Strongly Charged Particles in Solution of Electrolytes
  publication-title: Acta Physicochim. USSR
  contributor:
    fullname: Derjaguin
– volume: 339
  start-page: 281
  year: 2018
  ident: ref_17
  article-title: Impact of Dispersants on Dissolution of Itraconazole from Drug-Loaded, Surfactant-Free, Spray-Dried Nanocomposites
  publication-title: Powder Technol.
  doi: 10.1016/j.powtec.2018.08.014
  contributor:
    fullname: Li
– volume: 92
  start-page: 171
  year: 2015
  ident: ref_26
  article-title: Process Parameter Dependent Growth Phenomena of Naproxen Nanosuspension Manufactured by Wet Media Milling
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2015.02.031
  contributor:
    fullname: Bitterlich
– ident: ref_4
  doi: 10.3390/pharmaceutics8020017
– volume: 406
  start-page: 145
  year: 2011
  ident: ref_8
  article-title: Physical Stability of Nanosuspensions: Investigation of the Role of Stabilizers on Ostwald Ripening
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2010.12.027
  contributor:
    fullname: Verma
– volume: 62
  start-page: 1569
  year: 2010
  ident: ref_29
  article-title: Pharmaceutical Nanocrystals by Nanomilling: Critical Process Parameters, Particle Fracturing and Stabilization Methods
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.2010.01022.x
  contributor:
    fullname: Peltonen
– volume: 65
  start-page: 315
  year: 2013
  ident: ref_1
  article-title: Strategies to Address Low Drug Solubility in Discovery and Development
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.112.005660
  contributor:
    fullname: Williams
– volume: 104
  start-page: 3018
  year: 2015
  ident: ref_15
  article-title: In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.24155
  contributor:
    fullname: Kumar
– ident: ref_20
– volume: 15
  start-page: 91
  year: 1997
  ident: ref_38
  article-title: Wet Comminution in Stirred Media Mills
  publication-title: Kona Powder Part. J.
  doi: 10.14356/kona.1997013
  contributor:
    fullname: Kwade
– volume: 28
  start-page: 19
  year: 2020
  ident: ref_7
  article-title: Progress in the Development of Stabilization Strategies for Nanocrystal Preparations
  publication-title: Drug Deliv.
  doi: 10.1080/10717544.2020.1856224
  contributor:
    fullname: Li
– volume: s4-XII
  start-page: 382
  year: 1873
  ident: ref_25
  article-title: A Method of Geometrical Representation of the Thermodynamic Properties by Means of Surfaces
  publication-title: Trans. Conn. Acad. Arts Sci.
  contributor:
    fullname: Gibbs
– volume: 251
  start-page: 165
  year: 2003
  ident: ref_35
  article-title: Characterization of Solid Dispersions of Itraconazole and Hydroxypropylmethylcellulose Prepared by Melt Extrusion—Part I
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(02)00591-4
  contributor:
    fullname: Verreck
SSID ssj0000331839
Score 2.357084
Snippet Nanocrystal suspensions proved to be a potent enabling principle for biopharmaceutics classification system class II drugs with dissolution limited...
SourceID doaj
pubmedcentral
proquest
gale
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
StartPage 1528
SubjectTerms agglomeration
Cellulose acetate
Centrifugation
Chemical properties
Dosage and administration
Drug delivery systems
Drugs
dual centrifugation
Investigations
Itraconazole
media milling
nanocrystals
Nanoparticles
nanosuspension
Particle size
Pharmaceuticals
Stabilizing agents
Surfactants
Suspensions (Chemistry)
Vehicles
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQTxEoyEioXBqatR075lYKq5YDWmlb0VtkJ3YbaZWsSIK0_Wf8O2actLsBJC6cImVsJ_GM5-HMfCbkrZSGC-FmsbGGx6LQItZG8pjrclYCBWxkyPL9Kk8vxJfL9HLnqC_MCRvggYeJO4KAwDKwaxnYFeFnUpe-KDIEGhOpS9UQ-CRsJ5gKOpijrOqhZIdDXH-0vt5uEbcQVWRguLKJMQqY_X9q5t-zJXfMz_wheTD6jfR4eN9H5J6rH5ODxfC4zSE939ZRtYf0gC62kNSbJ-TnGYwJka-5aVaOgkZt2r5dY-46CB39URn6qYfRw1Zv5furwC6KP3EMxWpBsG8f6FkoqKSNp3NwdMdjv6ipSzpWG9CFwVQvxOukQFmMk0uX1Y0L7ZbNqirj4N_SE0x3D3t11LT0m1ut8LrsQCSvoEs34IdvnpKL-efzk9N4PLQhLoTSXexT7pn1EsycLWBJ28R7nxkDbPOW21mhuDWZn3lrXeZtkhrhIIpKirK0utSOPyN7dVO754QqhISS4OEVwosykQax_mTCGW5XaS8i8v6We_l6wObIIaZBdud_ZXdEPiKP7xojtHa4AQKXj3OS_0vgIvIOJSRHBYC8M2MdA7wzQmnlx4oJhXU3aUT2Jy1h4RZT8q2M5aPiaHOmEDeaCcki8uaOjD0xGa52TQ9tpIaPSZXiEVET2Zx82ZRSV9cBPFxzVOHsxf-YipfkPsNqkETFjO2Tve57716Bj9bZ12E5_gJw7T9D
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Databases
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELege-EF8SkCAxkJjZeFJbbjxLygbazaeJgquom9RXZid5WqpCwt0vaf8d9x57otAcRTpJyTOLnzfeXuZ0LeSam5EDaNtdE8FpUSsdKSx1zVaQ0UsJG-yvdcnl6KL1fZVUi4daGscq0TvaKu2wpz5AcsR0BdJiT7NP8e465R-Hc1bKFxn-ywlBfFgOwcnZyPvm6yLAlHmVWr1h0O8f3B_HqbKu4guijAgBU9o-Sx-__W0H9WTf5mhoaPyMPgP9LDFcMfk3u2eUL2RqvH3e7Ti20_VbdP9-hoC019-5T8PIN7QgSs79qZpaBZ227ZzbGGHYSP_phq-nkJd_cp36lbTjzbKP7M0RS7BsHOfaRnvrGSto4OweEN239R3dQ0dB3QkcaSL8TtpEAZBemk4-md9ePG7Wxax97PpcdY9u5zdlR39JudzfA4XoBoTuCSxQpH_PYZuRyeXByfxmHzhrgSuVrELuOOGSfB3JkKlrZJnHOF1rWrnOEmrXJudOFSZ4wtnEkyLSxEU0lV10bVyvLnZNC0jX1BaI7QUBI8vUo4USdSI-afTDjDtJVyIiIf1twr5yuMjhJiG2R3-U92R-QIebwZjBDb_kR7MynDNykhEjUMHKoCHBrhUqlg5lWBCHcis1meRuQ9SkiJigB5p0M_A8wZIbXKQxDWHPtvsojs9kbCAq765LWMlUGBdOVW3CPydkPGK7EorrHtEsZIBS-T5TmPSN6Tzd6b9SnN9NqDiCuOqpy9_P_DX5EHDPs9kjxmbJcMFjdL-xq8sIV5E5baL9-iOcM
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Open Access Journals
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9MwELfGeOEF8VdkDGQkNF6WkdiOEyMhNAbVhgSq1FXsLbITu6sUJaVpEd0349tx56YrgcFTpJzjOLk735199zMhL6XUXAgbh9poHopCiVBpyUOuyrgECthIn-X7RZ6OxaeL5GKHbAAVuh_Y3hja4XlS43l19OPb6h0o_FuMOCFkfz273K7-thAwZGCTslvkNgPjiFlenzuP30_OHIVY-b1mheerMb6u6_l3Tz2L5YH9_56-_0yp_M1GDe6Ru51zSY_X0nCf7Nj6ATkYrl-3OqTn22Kr9pAe0OEWt3r1kPw8gz4hPNZXTWUpTLtNu2xnmOAOkkm_TzX9sITe_Xrw1C0nnqcUd3o0xZJCMIJv6JmvuqSNowPwhruzwaiuS9qVJNChxnwwBPWkQBl2oktH0yvr242aalqG3gmmJ5gT7xf0qG7pV1tVeB0tQG4n8MhiDTK-ekTGg4_nJ6dhd7JDWIhULUKXcMeMk2ALTQF6byLnXKZ16QpnuImLlBududgZYzNnokQLC6FWVJSlUaWy_DHZrZvaPiE0RdwoCW5gIZwoI6kREFBGnOGalnIiIEcb7uWzNYBHDoEPsju_kd0BeY88vm6M-Nv-RjOf5N0_ySFMNQy8rQy8HeFiqWDkRYbwdyKxSRoH5BVKSI5yi7zTXbEDjBnxtvLjlIkUi3OSgOz3WoJ2F33yRsbyjXLkLEVwaSYkC8iLazI-iRlztW2W0EYq-JgkTXlA0p5s9r6sT6mnlx5hXHGc59ne_8f2lNxhWAwSpSFj-2R3MV_aZ-CiLcxzr3S_ANi0QHw
  priority: 102
  providerName: Scholars Portal
Title Itraconazole Nanosuspensions via Dual Centrifugation Media Milling: Impact of Formulation and Process Parameters on Particle Size and Solid-State Conversion as Well as Storage Stability
URI https://www.proquest.com/docview/2706272462
https://search.proquest.com/docview/2695285773
https://pubmed.ncbi.nlm.nih.gov/PMC9332252
https://doaj.org/article/289b207588534f169dfcc8136745e571
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe28cIL4lMERmUkNF6WNrGdL962smpD2hTRTewtshO7i5Ql1dIidf8Z_x13brouwBMvrdSzEyd35_vo3c-EfApDyYXQviuV5K7IE-EmMuQuTwq_AArYSFvlexGeXolv18H1Dgk2vTC2aD9X5bCubod1eWNrK-e3-WhTJzZKz8cQhIMYstEu2QXz-yhEt9svRzFN1t06HEL60fxmmx1uIaCIwWbhOX08QGMd855Jssj9f-_Pf9ZMPjJCk-fkWec90qP1Kl-QHV2_JAfp-s6rQ3q57aZqD-kBTbfA1KtX5NcZXBPiX3nfVJrCvtq0y3aOFewgevRnKenXJVzdJnxLs5xZplH8K0dS7BkEK_eFntm2StoYOgF3tzv8i8q6oF3PAU0lFnwhaicFStq9Ujot77UdN22qsnCtl0vHWPRuM3ZUtvSHrir8ni5AMGcwZbFGEV-9JleTk8vxqdsd3eDmIkoWrgm4YcqEYOxUDoqtPGNMLGVhcqO48vOIKxkb3yilY6O8QAoNsZSXF4VKikTzN2Svbmr9ltAIgaFC8PNyYUThhRIR_0KPM0xaJUY4ZLjhXjZfI3RkENkg57N_ct4hx8jjh8EIsG1_aO5mWfdOMohDFQN3KgZ3Rhg_TGDleYz4diLQQeQ75DNKSIbbAPJOdt0MsGYE1MqOIiYi7L4JHLLfGwnqm_fJGxnLuu2jzViE6NFMhMwhHx_IOBNL4mrdLGFMmMDDBFHEHRL1ZLP3ZH0KaJSFEO806N1_z3xPnjJsBPEil7F9sre4W-oP4J4t1IA8OT65SL8PbHoDPs9FPLAq-hu-MUTG
link.rule.ids 230,314,727,780,784,864,885,2102,2221,21388,24318,27924,27925,33744,33745,43805,53791,53793,74302
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELege4AXxKcIDDASGi8LS2Lnw7ygbaxqYVQV7cTeIjuxu0pVUpYWqfvP-O-4c92WAOIpUs5JnNz5vnL3MyFvkkQyznXoSyWZzwvBfSET5jNRhiVQwEbaKt9B0rvgny7jS5dwa1xZ5UYnWkVd1gXmyI-iFAF1I55EH-bffdw1Cv-uui00bpM9RE6PO2Tv5Gww_LrNsgQMZVasW3cYxPdH86tdqriB6CIDA5a1jJLF7v9bQ_9ZNfmbGereJ_ec_0iP1wx_QG7p6iE5GK4ftzqk410_VXNID-hwB029ekR-9uGeEAHLm3qmKWjWulk2c6xhB-GjP6aSflzC3W3Kd2qWE8s2ij9zJMWuQbBz72nfNlbS2tAuOLxu-y8qq5K6rgM6lFjyhbidFChDJ510NL3Rdtyonk1L3_q59BTL3m3OjsqGftOzGR5HCxDNCVyyWOOIrx6Ti-7Z-LTnu80b_IKnYuGbmJlImQTMnSpgaavAGJNJWZrCKKbCImVKZiY0SunMqCCWXEM0FRRlqUQpNHtCOlVd6aeEpggNlYCnV3DDyyCRiPmXBCzCtJUw3CPvNtzL52uMjhxiG2R3_k92e-QEebwdjBDb9kR9PcndN8khElUROFQZODTchImAmRcZItzxWMdp6JG3KCE5KgLknXT9DDBnhNTKj0FYU-y_iT2y3xoJC7hokzcyljsF0uQ7cffI6y0Zr8SiuErXSxiTCHiZOE2ZR9KWbLberE2pplcWRFwwVOXRs_8__BW50xt_Oc_P-4PPz8ndCHs_gtSPon3SWVwv9QvwyBbqpVt2vwCtQTyr
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELegkxAviE-RMcBIaLwsLIkdJ-EF7ataAVUR3cTeIjuxu0pVUpYWqfvP-O-4c92WAOIpUs5JnNz5vnL3MyFvhZCMcx36Uknm8zLjfiYF81lWhRVQwEbaKt-hOL_kn67iK1f_1LqyyrVOtIq6akrMkR9GCQLqRlxEh8aVReSn_Y-z7z7uIIV_Wt12GnfJDljFIOqRneOzYf51k3EJGMpvtmrjYRDrH86ut2njFiKNFIxZ2jFQFsf_b239ZwXlbyap_5A8cL4kPVox_xG5o-vHZD9fPW55QC-2vVXtAd2n-RamevmE_BzAPSEalrfNVFPQsk27aGdYzw6CSH9MJD1dwN1t-ndiFmPLQoo_diTFDkKweR_owDZZ0sbQPji_biswKuuKug4Emkss_0IMTwqU3EkqHU1utR03aqaTyrc-Lz3BEnibv6Oypd_0dIrH0RzEdAyXzFeY4sun5LJ_dnFy7ruNHPySJ9ncNzEzkTICTJ8qYZmrwBiTSlmZ0iimwjJhSqYmNErp1KggllxDZBWUVaWyKtPsGenVTa2fE5ogTJQAr6_khleBkIj_JwIWYQorM9wj79fcK2YrvI4C4hxkd_FPdnvkGHm8GYxw2_ZEczMu3DcpICpVEThXKTg33IQig5mXKaLd8VjHSeiRdyghBSoF5J10vQ0wZ4TXKo5AcBPsxYk9stcZCYu57JLXMlY4ZdIWW9H3yJsNGa_EArlaNwsYIzJ4mThJmEeSjmx23qxLqSfXFlA8Y6jWo93_P_w1uQcrrvgyGH5-Qe5H2AYSJH4U7ZHe_GahX4JzNlev3Kr7BR9dQNg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Itraconazole+Nanosuspensions+via+Dual+Centrifugation+Media+Milling%3A+Impact+of+Formulation+and+Process+Parameters+on+Particle+Size+and+Solid-State+Conversion+as+Well+as+Storage+Stability&rft.jtitle=Pharmaceutics&rft.au=Willmann%2C+Ann-Cathrin&rft.au=Berkenfeld%2C+Kai&rft.au=Faber%2C+Thilo&rft.au=Wachtel%2C+Herbert&rft.date=2022-07-22&rft.pub=MDPI+AG&rft.issn=1999-4923&rft.eissn=1999-4923&rft.volume=14&rft.issue=8&rft_id=info:doi/10.3390%2Fpharmaceutics14081528&rft.externalDocID=A724768625
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4923&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4923&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4923&client=summon